pentapeptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-03-05 and is reviewed periodically as new material appears.
In animal and early human studies, ipamorelin produces pulsatile growth hormone release and a secondary rise in insulin-like growth factor 1. The magnitude and duration of that rise depend on route, sampling schedule, and the baseline endocrine state of the subject. Whether repeated exposure alters the response over time is not firmly settled, since some reports describe stable pulsatility while others note attenuation. Most published data come from small samples, which limits the strength of any general claim about long-term behavior.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue class of compounds. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, a structure that differs from natural ghrelin in length and in the presence of non-natural amino acid residues. Early laboratory work described it as a comparatively selective agent that stimulates growth hormone release with limited effect on other pituitary hormones. The compound is supplied as a lyophilized solid for research use and has no identified natural source in the body.
Activity is mediated mainly through the growth hormone secretagogue receptor, now generally called the ghrelin receptor or GHS-R1a. Binding at this G-protein-coupled receptor triggers phospholipase C signaling, calcium mobilization, and release of growth hormone from pituitary somatotrophs. Reports describe less pronounced stimulation of adrenocorticotropic hormone and prolactin compared with earlier secretagogues such as hexarelin or GHRP-6. Selectivity figures vary between assay systems, so the degree of separation from other secretagogues is an area of ongoing comparison rather than a fixed constant.
Structural features distinguish the molecule from earlier secretagogues. An alpha-aminoisobutyric acid residue near the N-terminus and a D-naphthylalanine substitution increase receptor affinity, while C-terminal amidation improves resistance to exopeptidases. These modifications are associated with reduced stimulation of appetite and of the hypothalamic-pituitary-adrenal axis compared with hexarelin or growth hormone releasing peptide-6. Whether the same profile applies at every dose level studied is a matter of ongoing investigation rather than settled consensus.
Ipamorelin is a synthetic pentapeptide that acts as an agonist at the ghrelin receptor, also called the growth hormone secretagogue receptor type 1a. Its sequence incorporates non-natural residues, which slows enzymatic breakdown relative to short native peptides. In laboratory and early clinical work the compound is described as a selective growth hormone secretagogue because it raises growth hormone with comparatively little effect on other pituitary outputs. The degree to which that selectivity holds across species and dosing regimens remains an open question in the published literature.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic pentapeptide | GHS-R1a agonist family |
| Receptor target | Ghrelin receptor (GHS-R1a) | G-protein-coupled receptor |
| Sequence length | Five amino acid residues | Includes non-natural residues |
| Primary reported output | Pulsatile growth hormone release | Observed in animal and early human work |
| Molecular formula | C38H49N9O5 | Corresponds to roughly 711.9 g/mol |
Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.
Ipamorelin is a synthetic pentapeptide that belongs to the growth hormone secretagogue family. Its sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and its molecular mass is approximately 711.9 daltons. The compound was described in the late 1990s by researchers seeking molecules that release growth hormone with fewer side effects than earlier secretagogues. It is a laboratory and research compound, not an approved medicine in most jurisdictions.
At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.
One distinguishing feature reported in animal studies is selectivity. Ipamorelin stimulated growth hormone release with limited elevation of adrenocorticotropic hormone or cortisol compared with earlier secretagogues such as GHRP-6. This pattern has been described as more selective for the growth hormone axis. The finding comes mainly from preclinical work, and the degree to which it holds across species and doses is not fully settled. Reports also describe effects on gastric motility in animal models, suggesting activity outside the pituitary, though the clinical relevance of this observation is uncertain.
Ipamorelin is a synthetic pentapeptide that acts on the growth hormone secretagogue receptor, also known as the ghrelin receptor. Its sequence contains five amino acid residues, including a non-natural residue that increases stability against enzymatic breakdown. The compound was developed in the 1990s as part of research into small peptides that stimulate pituitary hormone release. Unlike larger protein hormones, it can be produced by solid-phase peptide synthesis and characterized by standard analytical methods.
At the receptor level, ipamorelin binds GHS-R1a and triggers signaling through Gq-coupled pathways. Activation leads to calcium release and downstream effects in pituitary somatotroph cells. These events promote the release of growth hormone into circulation. The response depends on the presence of the receptor and on the physiological state of the animal or tissue studied. Because the receptor is also found in other tissues, effects beyond the pituitary have been examined in laboratory models, though the extent of those effects remains an area of ongoing study.
== Operating units == NOCS currently has four facilities with over 15,000,000 cubic feet of refrigerated space located in three strategic port cities: New Orleans, LA; Houston, TX; and Charleston, SC.
== Climate == Climate Change Performance Index (CCPI) 2020: Of 57 nations responsible for about 90% of global energy-related CO2 emissions, Thailand was ranked 33rd, "poor". Other ASEAN nations ranked were Indonesia, 39 "poor" and Malaysia, 53 "very poor". Among other findings, Thailand's population and greenhouse gas (GHG) emissions continue to rise and its climate policy is "poor". Germanwatch's Global Climate Risk Index 2019 analyzes the extent to which countries have been affected by climate risks—impacts of weather-related loss events (storms, floods, heat waves, etc.). The most recent data available, for 2017 and from 1998 to 2017, are the basis of the report, which uses an algorithm based on deaths and financial losses. For the period 1998–2017, Thailand ranked 13 of 181 nations (1=most affected; 181=least affected). Other ASEAN nations were ranked: Myanmar, 3; Philippines, 5; Vietnam, 9; Cambodia, 19; Indonesia, 69; Laos, 89; Malaysia, 116; Brunei, 175; Singapore, 180. In 2019, YouGov surveyed 30,000 citizens in 28 nations about their views on climate change and the role of humans, if any, in causing it. Sixty-nine percent of Thais thought that the climate is changing and that humans were mostly responsible for it. Most of the people of other ASEAN nations surveyed were largely in agreement: Indonesia, 69%; Vietnam, 64%; Philippines, 62%; Singapore, 54%; and Malaysia, 48%. Global Climate Risk Index 2018: Thailand was ranked ninth on a list of countries most affected by extreme weather events during the period 1997–2016.
=== Cytogenetics === Cytogenetics is the study of chromosomes and chromosome abnormalities. While cytogenetics historically relied on microscopy to analyze chromosomes, new molecular technologies such as array comparative genomic hybridization are now becoming widely used. Examples of chromosome abnormalities include aneuploidy, chromosomal rearrangements, and genomic deletion/duplication disorders.
is the density of reagent ions in absence of reactant molecules in the buffer gas, k is the reaction rate constant and t is the average time the ions need to pass the reaction region. With a PTR-MS instrument the number of product and of reagent ions can be measured, the reaction rate constant can be found in literature for most substances and the reaction time can be derived from the set instrument parameters. Therefore, the absolute concentration of trace constituents
== Environmental Impact == Parcel to pallet sized insulated shipping containers have historically been single-use products due to the low-cost material composition of EPS and water-based gel packs. The insulation material typically finds its way into landfill streams as it is not readily recyclable in the United States. The development of reusable high-performance shipping containers have been shown to reduce packing waste by 95% while also contributing significant savings to other environmental pollutants.
Sources: en.wikipedia.org
On May 26, 2016, Green Berets supported about 80 soldiers of the Afghan 3rd Special Operations Battalion whose mission was to clear insurgents from Elbak, Kandahar province. The goal was to clear the road from Kandahar through Elbak to Tarin Kowt and allow an 800-man Afghan army convoy to deliver troops and supplies to Tarin Kowt. Green Berets called in three airstrikes by U.S. drones on Taliban insurgents near the landing zone, killing seven and wounding others. The mission had mixed results. The Taliban reoccupied the area and the convoy barely made any progress, however the operation interrupted the Taliban's nightly routine of bomb-planting. A week later, the Afghan commandos removed 18 booby-trap bombs from the road and made their way slowly through Elbak and further north. On August 23, a US soldier from A Company, 3rd battalion, 1st SFG, was killed by an IED while another was wounded along with six Afghans during a foot patrol near Lashkar Gah, Helmand Province. On October 4, 2016, a US soldier from B Company, 2nd Battalion, 10th SFG was killed by a roadside bomb blast in Achin, Nangarhar province. He was on a patrol with Afghan forces during an operation against ISIL-KP militants. This marked the first time a U.S. serviceman was killed in combat against IS militants in the country. On October 17, DEA agents, supported by a US Army Green Beret A-team and Afghan counter-narcotic units conducted a warranted search in a remote village in Farah province.
92A Automated Logistical Specialist 92F Petroleum Supply Specialist 92G Culinary Specialist 92L Petroleum Laboratory Specialist 92M Mortuary Affairs Specialist 92R Parachute Rigger 92S Shower/Laundry and Clothing Repair Specialist (RC) 92W Water Treatment Specialist 92Y Unit Supply Specialist 92Z Senior Noncommissioned Logistician
== Discontinuation of clinical development == During phase I human clinical trials for the treatment of cocaine abuse, development of JDTic was halted due to the occurrence of non-sustained ventricular tachycardia, a type of arrhythmia that can potentially be life-threatening. As a result, new KOR antagonists with more favorable drug profiles (e.g., short-acting, improved brain penetration, etc.), such as ALKS-5461 (a combination of buprenorphine and samidorphan) and CERC-501 (formerly LY-2456302), are being developed instead. The discontinuation of the clinical development of JDTic is detailed in the following important literature quote:
Berries are a type of simple fleshy fruit that issue from a single ovary. (The ovary itself may be compound, with several carpels.) The botanical term true berry includes grapes, currants, cucumbers, eggplants (aubergines), tomatoes, chili peppers, and bananas, but excludes certain fruits that are called "-berry" by culinary custom or by common usage of the term – such as strawberries and raspberries. Berries may be formed from one or more carpels (i.e., from the simple or compound ovary) from the same, single flower. Seeds typically are embedded in the fleshy interior of the ovary. Examples include:
Instead of cycling the wood in the chamber, heat can be added to the wood at a rate that matches the rate of sublimation of ice in the wood to water vapor, which is deposited on the inside of the chamber or in the cold trap. An advantage of freeze drying wood is that the form of the wood is maintained, and shrinkage does not typically occur. Shrinkage will occur over time after the wood is freeze dried, but this typically will not cause defects in the wood.
Sources: en.wikipedia.org
It is a synthetic pentapeptide in the growth hormone secretagogue family and acts as an agonist at the ghrelin receptor. It is handled as a laboratory research compound rather than a naturally occurring hormone.
Studies generally report growth hormone as the dominant output, with smaller or absent effects on adrenocorticotropic hormone and prolactin. The size of that separation depends on the assay and the dose examined, so it is best described as relative selectivity.
No natural source has been identified, and the molecule is produced by chemical synthesis. Its non-natural residues distinguish it from endogenous ghrelin even though both engage the same receptor.
Both molecules activate the same receptor, GHSR-1a, but they share little sequence identity. Ghrelin is a 28-amino-acid hormone carrying a distinctive acyl modification, whereas ipamorelin is a short synthetic peptide. The shared target explains overlapping endocrine effects, while the different structures account for differences in metabolic stability and receptor selectivity.